— Know what they know.
Not Investment Advice

LMAT NASDAQ

LeMaitre Vascular, Inc.
1W: +0.0% 1M: -11.8% 3M: +7.1% YTD: +24.1% 1Y: +17.9% 3Y: +58.0% 5Y: +111.6%
$97.75
-1.77 (-1.78%)
 
Weekly Expected Move ±5.1%
$87 $92 $97 $102 $107
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Strong Sell · Power 35 · $2.2B mcap · 21M float · 1.23% daily turnover · Short 76% of daily vol

Cash Flow Trends

Operating Cash Flow
$81M +84.1% ▲
5Y CAGR: +18.5%
Capital Expenditures
$7M +2.6% ▲
5Y CAGR: +17.9%
Free Cash Flow
$74M +100.4% ▲
5Y CAGR: +18.5%
Dividends Paid
$18M -25.9% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
$3M +96.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$27M$21M$30M$44M$58M
Depreciation & Amort.$11M$9M$10M$10M$10M
Stock-Based Comp.$3M$4M$5M$7M$0
Change in Working Capital-$10M-$13M-$11M-$20M-$2M
Other Non-Cash Items$4M$5M$2M$4M$13M
Operating Cash Flow$35M$25M$37M$44M$81M
— Investing Activities —
Capital Expenditures-$5M-$3M-$7M-$7M-$7M
Acquisitions (Net)$0$0-$899K$0-$2M
Investment Purchases-$59M-$8M-$17M-$278M-$641M
Investment Sales$3M$0$0$85M$585M
Other Investing$0$858K$0$0$0
Investing Cash Flow-$61M-$10M-$25M-$200M-$65M
— Financing Activities —
Net Debt Issuance-$39M$0$0$169M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid-$9M-$11M-$12M-$14M-$18M
Other Financing-$1M-$2M-$853K-$3M-$3M
Financing Cash Flow$14M-$9M-$7M$158M-$15M
Net Change in Cash-$13M$5M$5M$1M$3M
Cash End of Period$14M$19M$24M$26M$28M
Free Cash Flow$30M$22M$29M$37M$74M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms